Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.
01 2Symbiotec Pharmalab
02 1Gonane Pharma
03 1Axplora
04 1EUROAPI
05 1HRV Global Life Sciences
06 1Avik Pharmaceutical Limited
07 1Bayer AG
08 2Fujifilm Diosynth Biotechnologies
09 1Guangzhou Tosun Pharmaceutical
10 1Henan Lihua Pharmaceutical
11 1Laboratorio Syntex S.A
12 1Mac-Chem Products (India) Pvt.Ltd
13 1Maharshi Pharma Chem
14 2Pfizer Inc
15 1Quimica Sintetica
16 1SIMS Srl
17 2Tianjin Tianyao Pharmaceuticals Co., Ltd.
18 1Vaishali Pharma Ltd
19 1Zhejiang Xianju Pharmaceutical Co. Ltd
01 1Argentina
02 5China
03 1France
04 2Germany
05 8India
06 1Italy
07 1Spain
08 2U.S.A
09 2United Kingdom
01 8Active
02 7Inactive
03 8Blank
01 1Expired
02 6Valid
03 1Withdrawn by Holder
04 15Blank
01 23Blank
01 1WC-0162A2
02 1WC-0485
03 21Blank
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-07-21
Pay. Date : 2013-12-17
DMF Number : 27783
Submission : 2013-11-25
Status : Active
Type : II
Certificate Number : R1-CEP 2014-015 - Rev 01
Issue Date : 2022-05-03
Type : Chemical
Substance Number : 561
Status : Valid
Date of Issue : 2022-08-31
Valid Till : 2025-07-02
Written Confirmation Number : WC-0162A2
Address of the Firm :
NDC Package Code : 22552-0029
Start Marketing Date : 2011-08-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Registrant Name : Daeshin Pharmaceutical Co., Ltd.
Registration Date : 2023-01-11
Registration Number : 20210715-209-J-1022(2)
Manufacturer Name : Symbiotec Pharmalab Private Limited
Manufacturer Address : Plot No: 5, 6, 7 & 8, Special Economic Zone, Phase-II, Pharma zone, Pithampur, Dist. Dhar - 454 774(MP), India
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-10-01
Pay. Date : 2013-12-10
DMF Number : 3771
Submission : 1980-04-15
Status : Active
Type : II
Certificate Number : R1-CEP 1996-018 - Rev 09
Issue Date : 2021-12-16
Type : Chemical
Substance Number : 561
Status : Valid
NDC Package Code : 82298-118
Start Marketing Date : 2011-02-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34637
Submission : 2020-11-05
Status : Active
Type : II
NDC Package Code : 22552-0029
Start Marketing Date : 2011-08-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Registrant Name : Daeshin Pharmaceutical Co., Ltd.
Registration Date : 2023-01-11
Registration Number : 20210715-209-J-1022(2)
Manufacturer Name : Symbiotec Pharmalab Private Limited
Manufacturer Address : Plot No: 5, 6, 7 & 8, Special Economic Zone, Phase-II, Pharma zone, Pithampur, Dist. Dhar - 454 774(MP), India
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-03-02
Pay. Date : 2020-02-26
DMF Number : 25067
Submission : 2011-06-18
Status : Active
Type : II
Certificate Number : R1-CEP 2011-027 - Rev 01
Issue Date : 2021-03-22
Type : Chemical
Substance Number : 561
Status : Valid
NDC Package Code : 60722-1003
Start Marketing Date : 2016-01-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2022-10-24
Registration Number : 20221024-209-J-1384
Manufacturer Name : Zhejiang Xianju Pharmaceutical Co., Ltd.
Manufacturer Address : No.3 Donghai Fourth Avenue, Zhejiang Toumen Port Economic Development Zone, Linhai, Taizhou, Zhejiang, China
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4796
Submission : 1983-01-06
Status : Active
Type : II
Certificate Number : CEP 2006-058 - Rev 03
Issue Date : 2024-03-07
Type : Chemical
Substance Number : 561
Status : Valid
NDC Package Code : 0009-0038
Start Marketing Date : 2014-07-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31630
Submission : 2017-04-28
Status : Active
Type : II
Certificate Number : CEP 2021-208 - Rev 00
Issue Date : 2024-02-12
Type : Chemical
Substance Number : 561
Status : Valid
NDC Package Code : 64958-0084
Start Marketing Date : 1983-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17547
Submission : 2004-07-19
Status : Active
Type : II
Certificate Number : R1-CEP 2012-307 - Rev 01
Issue Date : 2022-10-04
Type : Chemical
Substance Number : 561
Status : Valid
NDC Package Code : 57582-011
Start Marketing Date : 2015-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2021-12-17
Registration Number : 20180706-209-J-239(3)
Manufacturer Name : Tianjin Tianyao Pharmaceuticals Co., Ltd
Manufacturer Address : No.19 Xinye 9th Street, west Area of Tianjin Economic-Technological Development Area, Tianjin, China.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-05
Pay. Date : 2013-09-16
DMF Number : 26458
Submission : 2012-09-18
Status : Active
Type : II
Certificate Number : R0-CEP 2006-265 - Rev 02
Issue Date : 2011-12-02
Type : Chemical
Substance Number : 561
Status : Expired
NDC Package Code : 57582-011
Start Marketing Date : 2015-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2021-12-17
Registration Number : 20180706-209-J-239(3)
Manufacturer Name : Tianjin Tianyao Pharmaceuticals Co., Ltd
Manufacturer Address : No.19 Xinye 9th Street, west Area of Tianjin Economic-Technological Development Area, Tianjin, China.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15912
Submission : 2002-03-25
Status : Inactive
Type : II
Certificate Number : R0-CEP 2000-361 - Rev 00
Issue Date : 2001-10-24
Type : TSE
Substance Number : 561
Status : Withdrawn by Holder
NDC Package Code : 0009-0038
Start Marketing Date : 2014-07-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3592
Submission : 1979-08-06
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3636
Submission : 1979-11-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4587
Submission : 1982-06-14
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 601
Submission : 1963-06-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6725
Submission : 1986-12-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6261
Submission : 1986-04-10
Status : Inactive
Type : II
Date of Issue : 2020-09-25
Valid Till : 2023-09-24
Written Confirmation Number : WC-0485
Address of the Firm :
Registrant Name : Hiple Co., Ltd.
Registration Date : 2024-03-26
Registration Number : 20240326-209-J-1628
Manufacturer Name : Avik Pharmaceutical Limited
Manufacturer Address : A-1/7 & A-1/8, 1ST Phase, GIDC, City : Vapi - 396 195, Dist. Valsad, Gujarat State, India
A (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one, including repackagers and relabelers. The FDA regulates (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one supplier is an individual or a company that provides (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one active pharmaceutical ingredient (API) or (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one finished formulations upon request. The (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one suppliers may include (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one API manufacturers, exporters, distributors and traders.
click here to find a list of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 19 companies offering (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?